Bausch Health Companies Inc. (BHC)
NYSE: BHC · Real-Time Price · USD
6.89
+0.06 (0.88%)
At close: Sep 18, 2025, 4:00 PM EDT
6.85
-0.04 (-0.58%)
After-hours: Sep 18, 2025, 4:40 PM EDT
Bausch Health Companies Employees
Bausch Health Companies had 20,700 employees as of December 31, 2024. The number of employees increased by 430 or 2.12% compared to the previous year.
Employees
20,700
Change (1Y)
430
Growth (1Y)
2.12%
Revenue / Employee
$476,232
Profits / Employee
$4,734
Market Cap
2.55B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 20,700 | 430 | 2.12% |
| Dec 31, 2023 | 20,270 | 370 | 1.86% |
| Dec 31, 2022 | 19,900 | 300 | 1.53% |
| Dec 31, 2021 | 19,600 | -2,000 | -9.26% |
| Dec 31, 2020 | 21,600 | -100 | -0.46% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
BHC News
- 7 days ago - Bausch Health: Repricing Continues As Deleveraging Gains Traction - Seeking Alpha
- 7 days ago - Bausch Health Completes Acquisition of DURECT Corporation, Expanding Late-stage Liver Disease Portfolio - Accesswire
- 7 days ago - Bausch + Lomb Announces Publication of enVista Envy™ Full Range of Vision Intraocular Lens Pivotal U.S. Clinical Trial - Business Wire
- 9 days ago - Bausch + Lomb Announces Publication of Data From a Prospective Study Evaluating the Efficacy of XIIDRA® in Alleviating Discomfort in Symptomatic Contact Lens Wearers - Business Wire
- 13 days ago - Bausch Health's Aesthetic Business, Solta Medical, Surpasses Milestone of 5 Million Skin Tightening Treatments with Thermage(R) Non-Surgical System - Accesswire
- 23 days ago - Bausch Health Announces Extension of DURECT Corporation Tender Offer to September 10, 2025 - Accesswire
- 4 weeks ago - Bausch Health, Canada Inc. Treatment for Acne Vulgaris, (Pr)CABTREO(TM) (Clindamycin Phosphate, Adapalene and Benzoyl Peroxide Gel), Now Available Through Public Drug Plans of Quebec and Saskatchewan - Accesswire
- 4 weeks ago - Bausch + Lomb board members resign after Icahn agreement ends - Reuters